초기 다계통위축증에 대한 뇌관류 Single Photon Emission Computed Tomography의 임상적 유용성 = Clinical Usefulness of 99mTc-Hexamethyl Propylene Amine Oxime Perfusion Single Photon Emission Computed Tomography for Early Phase Multiple System Atrophy

다국어 초록 (Multilingual Abstract)

Background: Clinical diagnosis of multiple system atrophy (MSA) relays on signs and symptoms that are often difficult to identify particularly at early stage. Indeed neuropathological studies have demonstrated that Parkinson variant of MSA (MSA-P) is the first cause of misdiagnosis in a cohort of patients presenting with parkinsonian features. But accurate diagnosis of these disorders is important for deciding on treatment, appropriate advice and prognosis since atypical parkinsonian disorders are characterized by poor response to dopaminergic treatment and more rapid disease progression. Therefore, we conducted this study to investigate difference of perfusion Single Photon Emission Computed Tomography (SPECT) in patients with the early phase of MSA-P using SPM program. Methods: We recruited consecutively 21 patients with MSA-P and 48 age-matched healthy controls. All subjects underwent Tc-99m HMPAO perfusion SPECT and this perfusion images were analyzed. Results: For MSA-P, only hypoperfusion was seen in the middle frontal gyrus of left frontal lobe, superior frontal gyrus of right frontal lobe, precentral gyrus of left frontal lobe, middle frontal gyrus of right frontal lobe and precentral gyrus of right frontal lobe with respect to healthy subjects. Conclusions: We cautiously assume that perfusion SPECT may offer significant advantages compared to other imaging techniques in the assessment of neuronal degeneration in MSA-P and may help the clinician in the diagnostic characterization of patients presenting with atypical parkinsonism.

참고문헌 (Reference)

1 Hughes AJ, "What features improve the accuracy of clinical diagnosis in parkinson’s disease : a clinicopathologic study" 42 : 1142-1146, 1992

2 Feigin A, "Tc-99m ethylene cysteinate dimer spect in the differential diagnosis of parkinsonism" 17 : 1265-1270, 2002

3 Van Laere K, "Statistical parametric mapping of (99m)tc-ecd spect in idiopathic parkinson’s disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters" 45 : 933-942, 2004

4 Paschali A, "Neuropsychological functions and rcbf spect in parkinson’s disease patients considered candidates for deep brain stimulation" 36 : 1851-1858, 2009

5 Wenning GK, "Multiple system atrophy : a review of 203 pathologically proven cases" 12 : 133-147, 1997

6 Firbank MJ, "Longitudinal change in 99mtchmpao cerebral perfusion spect in parkinson’s disease over one year" 76 : 1448-1451, 2005

7 Tang CC, "Differential diagnosis of parkinsonism : a metabolic imaging study using pattern analysis" 9 : 149-158, 2010

8 Juh R, "Different metabolic patterns analysis of parkinsonism on the 18f-fdg pet" 51 : 223-233, 2004

9 Gilman S, "Consensus statement on the diagnosis of multiple system atrophy" 163 : 94-98, 1999

10 Antonini A, "Complementary pet studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and parkinson’s disease" 120 (120): 2187-2195, 1997

11 Cilia R, "Brain spect imaging in multiple system atrophy" 112 : 1635-1645, 2005

12 Kimura N, "Brain perfusion differences in parkinsonian disorders" 26 : 2530-2537, 2011

13 Matsui H, "Brain perfusion differences between parkinson’s disease and multiple system atrophy with predominant parkinsonian features" 11 : 227-232, 2005

14 Hughes AJ, "Accuracy of clinical diagnosis of idiopathic parkinson’s disease : a clinico-pathological study of 100 cases" 55 : 181-184, 1992